ZERIA PHARMACEUTICAL CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,059 JPY | +0.54% |
|
+2.29% | +2.08% |
| 23/04 | Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints | CI |
| 16/02 | Zeria Pharmaceutical's Profit Up 41% in Fiscal Q1-Q3 | MT |
Chart calendar Zeria Pharmaceutical Co., Ltd.
794040e49f7f74d49eaab05.VoMm5mnliYvyyGZsVe697Q9GR4BmH7eabu_a9ISuhqg.ZuhSsj-t7sWE5QIgG6TvgUEvIeIeRvj0CqWssvWbt5o_znHUKJfA8pugAQ~04131846832afb21183e54b32ea50aaf
Upcoming events on Zeria Pharmaceutical Co., Ltd.
Past events on Zeria Pharmaceutical Co., Ltd.
| 28/03/2024 | Final dividend |
| 01/02/2024 | Q3 2023 Earnings Release |
| 01/11/2023 | Q2 2023 Earnings Release |
| 28/09/2023 | Ex-dividend day for dividende intermédiaire |
| 03/08/2023 | Q1 2023 Earnings Release |
| 11/05/2023 | Q4 2022 Earnings Release |
| 30/03/2023 | Ex-dividend day for final dividend |
| 02/02/2023 | Q3 2022 Earnings Release |
| 02/11/2022 | Interim 2022 Earnings Release |
| 29/09/2022 | Ex-dividend day for dividende intermédiaire |
| 04/08/2022 | Q1 2022 Earnings Release |
| 11/05/2022 | FY 2021 Earnings Release |
| 30/03/2022 | Ex-dividend day for final dividend |
| 02/02/2022 | Q3 2022 Earnings Release |
| 04/11/2021 | Interim 2021 Earnings Release |
| 29/09/2021 | Ex-dividend day for dividende intermédiaire |
| 05/08/2021 | Q1 2021 Earnings Release |
| 29/06/2021 | Shareholders Meeting |
| 11/05/2021 | FY 2020 Earnings Release |
| 30/03/2021 | Ex-dividend day for final dividend |
Past dividends on Zeria Pharmaceutical Co., Ltd.
| 28/03/2024 | Final Payment 22 JPY |
| 28/09/2023 | Interim Payment 22 JPY |
| 30/03/2023 | Final Payment 22 JPY |
| 29/09/2022 | Interim Payment 18 JPY |
| 30/03/2022 | Final Payment 18 JPY |
| 29/09/2021 | Interim Payment 17 JPY |
| 30/03/2021 | Final Payment 17 JPY |
| 29/09/2020 | Interim Payment 17 JPY |
| 30/03/2020 | Final Payment 17 JPY |
| 27/09/2019 | Interim Payment 17 JPY |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 61 831 62 000 -0.27% | 60 426 62 850 -3.86% | 55 442 56 900 -2.56% | 59 532 60 500 -1.6% | 68 383 68 100 0.42% | 75 000 |
|
EBITDA Million JPY | Released Forecast Spread | 7 471 7 250 3.05% | 8 039 6 860 17.19% | 7 878 7 902 -0.3% | 11 765 10 101 16.48% | 14 445 13 800 4.67% | 15 700 |
|
EBIT Million JPY | Released Forecast Spread | 3 737 3 600 3.81% | 4 094 4 150 -1.35% | 3 442 4 300 -19.95% | 6 366 5 550 14.7% | 9 014 9 700 -7.07% | 9 850 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 5 221 4 600 13.5% | 3 920 4 350 -9.89% | 3 922 5 079 -22.78% | 5 721 5 603 2.11% | 7 272 7 895 -7.89% | 10 520 |
|
Net income Million JPY | Released Forecast Spread | 3 454 3 200 7.94% | 2 925 3 275 -10.69% | 3 119 3 675 -15.13% | 3 961 3 900 1.56% | 6 195 6 680 -7.26% | 8 250 |
|
EPS JPY | Released Forecast Spread | 69,6 65,6 6.04% | 62,6 70,6 -11.24% | 67,7 80,0 -15.35% | 87,8 86,6 1.34% | 140 151 -7.33% | 187 |
| Announcement Date | 10/05/19 | 21/05/20 | 11/05/21 | 11/05/22 | 11/05/23 | - |
Quarterly results
| Fiscal Period | March | 2020 S1 | 2020 S2 | 2021 S1 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 30 317 30 500 -0.6% | 30 109 30 682 -1.87% | 26 809 28 000 -4.25% | 28 606 27 600 3.64% | 16 498 16 893 -2.34% | 14 428 14 895 -3.14% | 16 305 15 640 4.25% | 17 407 17 404 0.02% | 33 712 33 710 0.01% | 18 017 18 807 -4.2% | 16 654 15 770 5.61% | 18 304 17 190 6.48% | 18 374 18 295 0.43% | 36 678 36 600 0.21% | 21 241 19 470 9.1% | 17 780 |
|
EBIT Million JPY | Released Forecast Spread | 1 738 1 700 2.24% | 1 388 1 350 2.81% | 2 672 1 500 78.13% | 2 823 2 427 16.32% | 871 -195 546.67% | 2 977 1 700 75.12% | 2 917 2 902 0.52% | 5 894 5 880 0.24% | 2 656 2 105 26.18% | 464 -150 409.33% | 2 970 2 900 2.41% | 2 357 2 929 -19.53% | 5 327 5 900 -9.71% | 4 163 2 780 49.75% | 509 | |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 1 627 1 700 -4.29% | 1 979 | 3 119 2 200 41.77% | 2 508 1 883 33.19% | 2 972 1 700 74.82% | 1 998 2 185 -8.56% | 4 970 5 160 -3.68% | 1 769 2 117 -16.44% | 3 355 2 850 17.72% | 3 057 2 494 22.57% | 6 412 5 850 9.61% | 3 783 2 730 38.57% | 455 | |||
|
Net income Million JPY | Released Forecast Spread | 1 230 1 300 -5.38% | 1 218 1 200 1.5% | 2 115 1 496 41.38% | 1 928 1 384 39.31% | 2 601 1 360 91.25% | 1 397 1 388 0.65% | 3 998 3 990 0.2% | 1 982 1 841 7.66% | 215 179 20.11% | 2 915 2 365 23.26% | 2 481 1 940 27.89% | 5 396 4 855 11.14% | 3 027 2 008 50.75% | 76,0 | ||
|
EPS JPY | Released Forecast Spread | 26,2 | 30,1 | 46,7 | 42,7 | 58,7 | 90,4 | 44,9 | 66,1 | 122 | 68,7 | ||||||
| Announcement Date | 01/11/19 | 21/05/20 | 04/11/20 | 04/11/21 | 02/02/22 | 11/05/22 | 04/08/22 | 02/11/22 | 02/11/22 | 02/02/23 | 11/05/23 | 03/08/23 | 01/11/23 | 01/11/23 | 01/02/24 | - |
More events
Past sector events for Zeria Pharmaceutical Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4559 Stock
- Calendar Zeria Pharmaceutical Co., Ltd.
